Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in the Treatment of Male Patients With Isolated Hypogonadotropic Hypogonadism: an Open, Randomized Controlled Study

NCT03687606 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT03687606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03687606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in the Treatment of Male Patients With Isolated Hypogonadotropic Hypogonadism: an Open, Randomized Controlled Study
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
October 18, 2018
Completion date
October 1, 2025
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, isolated hypogonadotropic hypogonadism, kallmann syndrome